Patent US6494900B1 successfully refreshed from Google Patents.
US6494900B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for localized low energy photon therapy (LEPT)
Assignee: INTERNATIONAL MEDICAL INSTRUMENTS Inc
•
Filing: 2000-01-31
•
Granted: 2002-12-17
•
Expires: 2020-01-31
Abstract
Abstract Novel apparatus for treating a disorder of a biological tissue in a mammal by stimulating the biological tissue with light having selected optical parameters. The apparatus has a power source, a central microprocessor with stored optical parameter protocols and wireless probes to receive the protocols and to generate and transmit the light. The invention also relates to a method for stimulating healing of a disorder of a biological tissue in a mammal by stimulating the biological tissue with light having selected optical parameters.
Inventors
- 👤 Norman Salansky
- 👤 Natalia Filonenko
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 19:44
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/06; A61N5/0613; A61N5/0616; A61N2005/0635; A61N2005/0643; A61N2005/0645; A61N2005/065; A61N2005/0651; A61N2005/0652; A61N5/0624
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
173 words
A method for stimulating healing of a dermatological, musculoskeletal, soft tissue or neurological disorder of a biological tissue in a mammal by stimulating the biological tissue with low energy light having selected optical parameters, comprising: (a) providing a central microprocessor having stored optical parameter protocols suitable for treating a range of disorders of biological tissue, said parameters including wavelength, power, intensity and dose; (b) selecting a stored optical parameter protocol for the disorder to be treated; and (c) providing an array of light emitting sources, all of said sources when activated producing substantially monochromatic non-ionizing light having a selected wavelength in the range of from 630 to 2000 nm and a bandwidth not exceeding substantially 30 to 40 nm, and each of said sources providing light of the same said selected wavelength; (d) activating selected ones of said light emitting sources to produce a desired three dimensional light distribution at said tissue according to the selected optical parameter protocol; and (e) directing the beam of light to the biological tissue to be treated.
Claim 2
Independent Claim
173 words
A method for stimulating healing of a dermatological, musculoskeletal, soft tissue or neurological disorder of a biological tissue in a mammal by stimulating the biological tissue with low energy light having selected optical parameters, comprising: (a) providing a central microprocessor having stored optical parameter protocols suitable for treating a range of disorders of biological tissue, said parameters including wavelength, power, intensity and dose; (b) selecting a stored optical parameter protocol for the disorder to be treated; and (c) providing an array of light emitting sources, all of said sources when activated producing substantially monochromatic non-ionizing light having a selected wavelength in the range of from 630 to 2000 nm and a bandwidth not exceeding substantially 30 to 40 nm, and each of said sources providing light of the same said selected wavelength; (d) activating selected ones of said light emitting sources to produce a desired three dimensional light distribution at said tissue according to the selected optical parameter protocol; and (e) directing the beam of light to the biological tissue to be treated.
Claim 3
Independent Claim
179 words
A method of stimulating healing of a lesion in a mammal, comprising: irradiating the lesion with a beam of light using an array of light emitting sources, selected ones of said light emitting sources being activated to produce a desired three dimensional light distribution at said lesion, all of said sources when activated producing substantially monochromatic non-ionizing light having a selected wavelength in the range of from 630 to 2000 nm and a bandwidth not exceeding substantially 30 to 40 nm, and each of said sources providing light of the same said selected wavelength and no other wavelength, said beam of light having predetermined optical parameters, wherein the predetermined optical parameters include a dose of from 0.05 to 25 J/cm 2 , an intensity of from 0.2 to 5000 mW/cm 2 , a continuous wave mode or a pulse repetition rate of from 0 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of from 0.2 to 0.3 Hz, 1 to 1.2 Hz, and 1 to 5 Hz.
Claim 4
Independent Claim
179 words
A method of stimulating healing of a lesion in a mammal, comprising: irradiating the lesion with a beam of light using an array of light emitting sources, selected ones of said light emitting sources being activated to produce a desired three dimensional light distribution at said lesion, all of said sources when activated producing substantially monochromatic non-ionizing light having a selected wavelength in the range of from 630 to 2000 nm and a bandwidth not exceeding substantially 30 to 40 nm, and each of said sources providing light of the same said selected wavelength and no other wavelength, said beam of light having predetermined optical parameters, wherein the predetermined optical parameters include a dose of from 0.05 to 25 J/cm 2 , an intensity of from 0.2 to 5000 mW/cm 2 , a continuous wave mode or a pulse repetition rate of from 0 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of from 0.2 to 0.3 Hz, 1 to 1.2 Hz, and 1 to 5 Hz.
Claim 5
Dependent Claim
84 words
The method of claim 2 wherein the lesion is an ulcer or a wound and the selected optical parameters include a dose of from 0.05 to 0.2 J/cm 2 , a wavelength of from 600 to 700 nm, a continuous wave mode or pulse repetition rate of from 0 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of from 0.2 to 0.3 Hz, 1 to 1.2 Hz, and 1 to 5 Hz.
Claim 6
Dependent Claim
98 words
The method of claim 2 wherein the lesion is an ulcer or wound in acute inflammatory condition and the selected optical parameters include a dose of from 2.0 to 5.0 J/cm 2 , an intensity of from 10.0 to 30 mW/cm 2 , and a wavelength of from 600 to 700 nm, a continuous wave mode or pulse repetition rate of from 0 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of from 0.2 to 0.3 Hz., 1 to 1.2 Hz, and 1 to 5 Hz.
Claim 7
Dependent Claim
92 words
The method of claim 2 wherein the lesion is an infected wound and the selected optical parameters include a dose of from 3.0 to 9.0 J/cm 2 , an intensity of from 50.0 to 80 mW/cm 2 and a wavelength of from 600 to 700 nm, a continuous wave mode or pulse repetition rate of from 0 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of from 0.2 to 0.3 Hz, 1 to 1.2 Hz, and 1 to 5 Hz.
Claim 8
Dependent Claim
108 words
The method of claim 2 wherein the lesion is an ulcer or a wound in the area with impaired microcirculation and the selected optical parameters include a dose of from 0.1 to 9.0 J/cm 2 , an intensity of from 300 to 600 mW/cm 2 and a wavelength of from 800 to 1,100 nm in a continuous wave (CW) mode or with pulse repetition rate of 10 Hz or from 50 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of 0.3 and/or 1.2 Hz and the area to be treated is the skin surrounding the lesion.
Claim 9
Dependent Claim
332 words
The method of claim 2 where the lesion is an ulcer or wound and the selected optical parameters include a suitable combination of one or more of the following optical parameters: (a) a dose of from 0.05 to 0.2 J/cm 2 , a wavelength of from 600 to 700 nm, a continuous wave mode or pulse repetition rate of from 0 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of from 0.2 to 0.3 Hz, 1 to 1.2 Hz, and 1 to 5 Hz; (b) a dose of from 2.0 to 5.0 J/cm 2 , an intensity of from 10.0 to 30 mW/cm 2 , and a wavelength of from 600 to 700 nm, a continuous wave mode or pulse repetition rate of from 0 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of from 0.2 to 0.3 Hz, 1 to 1.2 Hz, and 1 to 5 Hz; (c) a dose of from 3.0 to 9.0 J/cm 2 , an intensity of from 50.0 to 80 mW/cm 2 and a wavelength of from 600 to 700 nm, a continuous wave mode or pulse repetition rate of from 0 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of from 0.2 to 0.3 Hz, 1 to 1.2 Hz, and 1 to 5 Hz; and (d) a dose of from 0.1 to 9.0 J/cm 2 , an intensity of from 300 to 600 mW/cm 2 and a wavelength of from 800 to 1,100 nm in a continuous wave (CW) mode or with pulse repetition rate of 10 Hz or from 50 to 200 Hz, and optional modulation frequencies of said continuous wave mode or of said pulse repetition rate of any of 0.3 and/or 1.2 Hz; wherein the suitable combination depends on the ulcer or wound condition or stage.
Claim 10
Dependent Claim
51 words
The method of claim 2 wherein the lesion is a post-surgical scar in an acute inflammatory condition and the selected optical parameters include a dose of from 2 to 5 J/cm 2 , an intensity of from 10 to 30 mW/cm 2 and a wavelength of from 600 to 700 nm.
Claim 11
Dependent Claim
73 words
The method of claim 2 wherein the lesion is a post-surgical scar in a sub-acute inflammatory condition and the selected optical parameters include a dose of from 3 to 7 J/cm 2 or 4 to 25 J/cm 2 , an intensity of from 10 to 40 mW/cm 2 or 60 to 100 mW/cm 2 or 300-600 mW/cm 2 or 1000 to 5000 mW/cm 2 and a wavelength of from 800 to 1100 nm.
Claim 12
Dependent Claim
52 words
The method of claim 2 wherein the lesion is induced by Herpes Simplex virus (cold sore) or acne and the selected optical parameters include a dose of from 4 to 9 J/cm 2 , an intensity of from 20 to 60 mW/cm 2 and a wavelength of from 630 to 700 nm.
References Cited (Backward Citations)
US4440160A
Cited
US5409479A
Cited
US4669466A
Cited
US4930504A
Cited
US5312396A
Cited
US5549660A
Cited
US5755751A
Cited
US5638593A
Cited
US5674217A
Cited
US5735285A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2005-12-16 | 2006-06-17 | 2006-12-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2009-12-16 | 2010-06-17 | 2010-12-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2013-12-16 | 2014-06-17 | 2014-12-17 | $7700.00 | Window Closed / Lapsed |